Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The researchers' laboratory is studying a rare class of highly recurrent hydatidiform moles. These are usually complete hydatidiform moles (CHM), but sometimes they are partial hydatidiform moles PHM). With sporadic moles, the difference between CHMs and PHMs is that with CHMS, there is not typically an embryo or fetus at the time of diagnosis but with a PHM there may be a fetus. Also, CHMs have 46 chromosomes in each cell. While this is the number of chromosomes that should be found, the problem is that all the chromosomes come from the father. Normally, half the chromosomes should come from the mother and half should come from the father. Unlike CHMs, PHMs have 69 chromosomes. This means that PHMs have three copies of each chromosome when they should only have two. The extra copy comes from the father.
The researchers' study focuses on moles that are genetically different from these sporadic moles in that they have 23 chromosomes from the mother and 23 chromosomes from the father - just like a normally developing pregnancy. These are called biparental moles because the mutation that causes the mole comes from both parents. This mutation occurs in a gene called NLRP7. The researchers' team is working to understand how mutations in NLRP7 leads to CHMs and how these mutations may lead to other types of pregnancy loss. The researchers are also trying to discover other genetic and epigenetic factors that may lead to moles.
| Condition |
|---|
|
Hydatidiform Moles |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Genetic Studies in Gestational Trophoblastic Disease |
lymphoblast DNA; tissue
| Estimated Enrollment: | 100 |
| Study Start Date: | December 1998 |
| Estimated Study Completion Date: | January 2018 |
| Groups/Cohorts |
|---|
|
A.
Individuals with recurrent or sporadic hydatidiform moles and their first-degree family members. Sometimes additional family members are also enrolled.
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Individuals who have had sporadic or recurrent hydatidiform moles and their first degree relatives. Sometimes additional family members are also enrolled.
Inclusion Criteria:
- Personal or family history of recurrent moles or a sporadic mole
- Presence of a mutation in NLRP7
Contacts and Locations| Contact: Ivonne Curiel | 713-873-3674 | icuriel@bcm.edu |
| Contact: Ignatia B Van den Veyver, MD | 713-798-4914 | iveyver@bcm.edu |
| United States, Texas | |
| Baylor College of Medicine | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Ignatia B Van den Veyver, MD 713-798-4914 iveyver@bcm.edu | |
| Contact: Ivonne Curiel 713-873-3674 icuriel@bcm.edu | |
| Principal Investigator: Ignatia B Van den Veyver, MD | |
| Principal Investigator: | Ignatia B Van den Veyver, MD | Baylor College of Medicine |
More Information
Publications:
| Responsible Party: | Ignatia B. Van den Veyver, Baylor College of Medicine |
| ClinicalTrials.gov Identifier: | NCT01008501 History of Changes |
| Other Study ID Numbers: | BCM Hydatidiform Mole H7345 |
| Study First Received: | November 4, 2009 |
| Last Updated: | December 21, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Baylor College of Medicine:
|
hydatidiform moles complete hydatidiform moles partial hydatidiform moles Molar pregnancy NLRP7 |
pregnancy wastage imprinting sporadic hydatidiform moles recurrent hydatidiform moles |
Additional relevant MeSH terms:
|
Hydatidiform Mole Gestational Trophoblastic Neoplasms Trophoblastic Neoplasms Neoplasms, Germ Cell and Embryonal |
Neoplasms by Histologic Type Neoplasms Pregnancy Complications, Neoplastic Pregnancy Complications |
ClinicalTrials.gov processed this record on May 23, 2013